# Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors

> **NCT02419105** · PHASE3 · TERMINATED · sponsor: **University of Zurich** · enrollment: 91 (actual)

## Conditions studied

- Hypogonadism
- Pre-frail Seniors

## Interventions

- **DRUG:** Testosterone
- **DRUG:** Colecalciferol
- **DRUG:** Placebo drink solution
- **DRUG:** Placebo transdermal gel

## Key facts

- **NCT ID:** NCT02419105
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2020-05
- **Final completion:** 2020-06
- **Target enrollment:** 91 (ACTUAL)
- **Why stopped:** Delayed recruitment mainly due to a screening to inclusion rate much lower than expected. Due to the delayed recruitment IMP reached the end of its shelf life.
- **Last updated:** 2020-06-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419105, "Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02419105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*